Skip to main content
EMA Logo
  • Medicines
    Medicines

    • Search
    • Download
    • What we publish and when
    • Medicines under evaluation
    • National registers
  • Human regulatory
    Human regulatory

    • Overview
    • Research and development
    • Marketing authorisation
    • Post-authorisation
    • Herbal products
  • Veterinary regulatory
    Veterinary regulatory

    • Overview
    • Research and development
    • Marketing authorisation
    • Post-authorisation
  • Committees
    Committees

    • How the committees work
    • CHMP
    • CVMP
    • PRAC
    • COMP
    • HMPC
    • CAT
    • PDCO
    • Working parties and other groups
  • News & events
    News & events

    • News and press releases
    • Events
    • What's new
    • Committee highlights
    • Therapeutic areas: latest updates
    • Publications
    • Press and social media
    • Open consultations
    • RSS feeds
  • Partners & networks
    Partners & networks

    • EU partners
    • International activities
    • Patients and consumers
    • Healthcare professionals
    • Academia
    • Pharmaceutical industry
    • Networks
    • Health technology assessment bodies
  • About us
    About us

    • What we do
    • Who we are
    • How we work
    • Annual reports and work programmes
    • History of EMA
    • Careers
    • Procurement
    • Glossaries
    • About this website
    • Data protection and privacy
    • FAQs
    • Contacts

COVID-19 pandemic

All info here

QUICK LINKS

  • Latest updates
  • Vaccines
  • Treatments
  • Guidance for developers and companies
  • First anniversary of DARWIN EU®
    DARWIN EU
    Real-world evidence |Regulatory

    First anniversary of DARWIN EU®

  • First anniversary of DARWIN EU®
    DARWIN EU
    Real-world evidence |Regulatory

    First anniversary of DARWIN EU®

    DARWIN EU® has completed its first studies, generating real-world evidence to support regulatory decision making. A call to onboard ten additional data partners in 2023 is now open.

  • Achievements of the Regulatory Science Strategy
    Regulatory Science |Report

    Achievements of the Regulatory Science Strategy

  • Achievements of the Regulatory Science Strategy
    Regulatory Science |Report

    Achievements of the Regulatory Science Strategy

    EMA published a report summarising the mid-term achievements of the Regulatory Science Strategy to 2025

  • Human medicines: highlights of 2022
    Medicines |Highlights

    Human medicines: highlights of 2022

  • Human medicines: highlights of 2022
    Medicines |Highlights

    Human medicines: highlights of 2022

    EMA recommended 89 human medicines for marketing authorisation in 2022. Check out our overview of key recommendations on the authorisation and safety monitoring of human medicines

  • Veterinary medicines: highlights of 2022
    Medicines |Highlights

    Veterinary medicines: highlights of 2022

  • Veterinary medicines: highlights of 2022
    Medicines |Highlights

    Veterinary medicines: highlights of 2022

    EMA recommended 10 veterinary medicines for marketing authorisation in 2022. Check out our overview of key recommendations on the authorisation and safety monitoring of veterinary medicines

Search for medicines
Search for information on human, veterinary or herbal medicines.
What's new
Find all the latest news and updates published on this website in one place.
FAQs
Find answers to the most frequently asked questions we receive.

Latest news

  • List item
    28/03/2023

    DARWIN EU® has completed its first studies and is calling for new data partners

    DARWIN EU® , the Data Analysis and Real-World Interrogation Network, has accomplished its first year of establishment. Following the set-up of the DARWIN EU® Coordination Centre in February 2022, the first ten data partners were onboarded. The...

  • List item
    24/03/2023

    Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 21-22 March 2023

    CVMP opinions on veterinary medicinal products Under Regulation (EC) No 726/2004 The Committee adopted by consensus a positive opinion for a marketing authorisation of Newflend ND H9, from Ceva-Phylaxia Co. Ltd., a new vaccine for the active...

  • List item
    22/03/2023

    Advancing regulatory science in the EU – mid-point report published

    EMA has published a report summarising the mid-term achievements of its Regulatory Science Strategy (RSS) to 2025 . The report provides an overview of the main deliverables achieved between March 2020 and December 2022 across the human and...

  • List item
    17/03/2023

    EMA Management Board: highlights of March 2023 meeting

    The Management Board was updated on the ongoing efforts of EMA’s Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) to closely monitor several critical shortages of medicines in the EU/EEA, in particular medicines...

  • List item
    17/03/2023

    Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13 - 16 March 2023

    At its monthly meeting, EMA’s safety committee (PRAC) carried out its broad range of responsibilities, which cover all aspects of the risk management of the use of medicines: assessment of safety signals, risk management plans, periodic safety...

  • List item
    27/02/2023

    EMA pilots scientific advice for certain high-risk medical devices

    EMA has launched a pilot to give scientific advice on the intended clinical development strategy and proposals for clinical investigation for certain high-risk medical devices (all class III devices and class IIb active devices intended to...

  • Load more news

Information for you

Patients and carers
Featured news and updates for patients and carers
Healthcare professionals
Featured news and updates for healthcare professionals, including doctors, nurses and pharmacists
Animal health professionals
Featured news and updates for animal health professionals and users of veterinary medicines such as pet owners
Pharmaceutical industry
Featured news and updates for pharmaceutical industry stakeholders active in the human and veterinary medicines fields
Media
Featured news and updates for journalists with a professional interest in the development and availability of medicines in the European Union
Academia
Featured news and updates for European academics and researchers in the field of medicine development

Key content

  • List item

    Product emergency hotline

  • List item

    UK’s withdrawal from the EU

  • List item

    PRIME: Priority medicines

  • List item

    Pharmacovigilance (safety monitoring)

  • List item

    Data on medicines

  • List item

    Clinical data publication

  • List item

    Careers

Services & databases

  • List item

    Clinical Trials website

  • List item

    Account Management portal

  • List item

    eSubmission

  • List item

    EudraVigilance (human)

  • List item

    EudraVigilance Veterinary

  • List item

    Veterinary Medicines information website

  • List item

    Suspected adverse drug reactions database

  • List item

    Clinical data

  • List item

    SPOR data management services

  • List item

    Service Desk

  • List item

    IRIS platform

  • List item

    Public register of parallel distribution notices

  • List item

    European Vaccination Information Portal

How does EMA work?

  • List item

    What we do

  • List item

    Our role in authorisation of medicines

  • List item

    Who we are

  • List item

    Our scientific experts

  • List item

    How we work

  • List item

    What we publish

Product emergency hotline
outside working hours
  • About us
  • What we do
  • Careers
  • Committees
  • Regulatory network
  • Languages
  • Frequently asked questions
  • Glossaries
  • About this website
  • Privacy
  • Search tips
  • Access to documents
  • Contacts
  • Send a question
  • EMA Service desk (system support)

European Medicines Agency
Domenico Scarlattilaan 6
1083 HS Amsterdam
The Netherlands

Tel: +31 (0)88 781 6000

How to find us

Postal address and deliveries

Business hours and holidays

For the United Kingdom, as of 1 January 2021, European Union law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland / NI.
RSS feed Twitter YouTube LinkedIn
© 1995-2023 European Medicines Agency
European Union agencies network
European Union agencies network
An agency of the European Union
European Union flag